癌细胞分泌的miR-33a通过向瘤中的多胺代谢来减少压力颗粒的形成
在PubMed上查看摘要
概括
此摘要是机器生成的。癌细胞在营养压力下通过细胞外囊 (EVs) 分泌miR- 33a,向癌症相关的纤维细胞以提高瘤的存活率. 这一过程涉及铁含量,多胺代谢和表观遗传调节.
科学领域
- 分子生物学
- 癌症生物学
- 表观遗传学
背景情况
- 瘤进展依赖于瘤微环境 (TME) 内的复杂相互作用.
- 细胞外囊泡 (EVs) 介导癌细胞和层细胞之间的通信.
- 在营养饥饿期间癌细胞衍生的EV的机制和影响尚不清楚.
研究的目的
- 在葡萄糖和铁缺乏的情况下阐明癌细胞衍生的EV分泌的机制.
- 研究外体miR-33a对癌症相关纤维细胞 (CAF) 的生物学影响.
- 了解多胺代谢和表观遗传修饰在瘤存活中的作用.
主要方法
- 在葡萄糖和缺铁条件下分析EV分泌物.
- 在EV货物选择中涉及的RNA结合蛋白的识别 (例如,ACO1).
- 目标基因预测和验证 (例如,AGMAT,KDM5C) 和表观遗传修饰 (H3K4me3) 的评估.
主要成果
- 在低葡萄糖和铁的条件下,癌细胞通过EVs选择性地分泌miR- 33a.
- 外体miR-33a对CAF中的AGMAT进行向,抑制的生物合成.
- 减少的素会导致KDM5C的上调,影响TIA1基因表达和结构压力颗粒的形成.
结论
- 瘤利用一种涉及铁和营养水平的新机制来调节miR-33a的EV分泌.
- 外体 miR-33a 通过 miR-33a/KDM5C/H3K4me3 轴重塑体内压力颗粒的形成.
- 这种EV介导的通信在TME的营养缺乏条件下增强了癌细胞的存活率.
相关概念视频
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

